Brain metastases in HER2-positive breast cancer

被引：8
|
作者：
Lin, Nancy U. [1 ]
机构：
[1] Dana Farber Canc Inst, Dept Med Oncol, Div Womens Canc, Boston, MA 02215 USA
来源：
LANCET ONCOLOGY | 2013年 / 14卷 / 03期
关键词：
NERVOUS-SYSTEM METASTASES; TRASTUZUMAB; LAPATINIB; WOMEN;
D O I：
10.1016/S1470-2045(13)70046-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：185 / 186
页数：3
相关论文
共 50 条
  • [1] Neratinib in HER2-Positive Breast Cancer With Brain Metastases
    Dekker, Tim Johannes Adrianus
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03) : 251 - +
  • [2] Treatment of brain metastases of HER2-positive breast cancer
    Heudel, P.
    Tredan, O.
    Cassier, P.
    Ray-Coquard, I.
    Guastalla, J. -P.
    Bachelot, T.
    ONCOLOGIE, 2012, 14 (01) : 41 - 44
  • [3] Brain metastases from HER2-positive breast cancer
    Susheela, Sridhar Papaiah
    Revannasiddaiah, Swaroop
    Madhusudhan, N.
    Basavalingaiah, Ajaikumar
    LANCET ONCOLOGY, 2013, 14 (01): : E3 - E3
  • [4] Brain metastases in HER2-positive breast cancer: challenges and opportunities
    Torrejon, Davis
    Di Cosimo, Serena
    ANNALS OF PALLIATIVE MEDICINE, 2012, 1 (03) : 195 - 197
  • [5] Temozolomide in secondary prevention of HER2-positive breast cancer brain metastases
    Zimmer, Alexandra S.
    Steinberg, Seth M.
    Smart, Dee Dee
    Gilbert, Mark R.
    Armstrong, Terri S.
    Burton, Eric
    Houston, Nicole
    Biassou, Nadia
    Gril, Brunilde
    Brastianos, Priscilla K.
    Carter, Scott
    Lyden, David
    Lipkowitz, Stanley
    Steeg, Patricia S.
    FUTURE ONCOLOGY, 2020, 16 (14) : 899 - 909
  • [6] LAPATINIB AND CAPECITABINE IN THE TREATMENT OF HER2-POSITIVE BREAST CANCER WITH BRAIN METASTASES
    Dubianski, R.
    Brewczynska, E.
    Lemanska, I.
    Szombara, E.
    Nowecki, Z. I.
    ANNALS OF ONCOLOGY, 2014, 25
  • [7] Characteristics of patients with brain metastases from HER2-positive breast cancer
    Laakmann, E.
    Witzel, I.
    Neunhoeffer, T.
    Park-Simon, T-W.
    Weide, R.
    Riecke, K.
    Polasik, A.
    Schmidt, M.
    Puppe, J.
    Mundhenke, C.
    Luebbe, K.
    Hesse, T.
    Thill, M.
    Zahm, D-M.
    Denkert, C.
    Fehm, T.
    Nekljudova, V.
    Rey, J.
    Loibl, S.
    Mueller, V.
    ANNALS OF ONCOLOGY, 2021, 32 : S63 - S64
  • [8] Appearance and therapy of brain metastases in patients with HER2-positive breast cancer
    Witzel, I
    Hemminger, G.
    Ihnen, M.
    Jaenicke, F.
    Mueller, V
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2008, 68 : S137 - S137
  • [9] Tyrosine kinase inhibitors for brain metastases in HER2-positive breast cancer
    Duchnowska, Renata
    Loibl, Sibylle
    Jassem, Jacek
    CANCER TREATMENT REVIEWS, 2018, 67 : 71 - 77
  • [10] Brain metastases in HER2-positive breast cancer: The evolving role of lapatinib
    Tomasello, Gianluca
    Bedard, Philippe L.
    de Azambuja, Evandro
    Lossignol, Dominique
    Devriendt, Daniel
    Piccart-Gebhart, Martine J.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2010, 75 (02) : 110 - 121
12345